Nanobiotix S.A. ADR (NBTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 06-2025 | 12-2024 | 06-2024 | 12-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 59,681 | 32,714 | 53,820 | 71,436 | 81,479 |
| Receivables | 2,417 | 2,085 | 3,221 | 3,361 | 979 |
| Other current assets | 8,897 | 10,482 | 9,471 | 11,846 | 12,069 |
| TOTAL | $70,995 | $45,282 | $66,512 | $86,643 | $94,527 |
| Non-Current Assets | |||||
| PPE Net | 19,242 | 5,521 | 17,918 | 17,359 | 17,005 |
| Investments And Advances | 491 | 464 | 439 | 332 | 324 |
| Intangibles | 0 | 15 | 0 | 0 | 0 |
| Other Non-Current Assets | 11 | 0 | 8 | 10 | 9 |
| TOTAL | $19,744 | $6,000 | $18,365 | $17,701 | $17,338 |
| Total Assets | $76,664 | $51,282 | $72,953 | $93,346 | $101,625 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 10,320 | 13,213 | 21,681 | 20,611 | 19,738 |
| Other current liabilities | 54,745 | 58,289 | 42,095 | 40,251 | 34,241 |
| TOTAL | $65,063 | $71,560 | $63,774 | $60,862 | $53,978 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | 57 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 107,183 | 57,996 | 80,279 | 55,934 | 49,641 |
| TOTAL | $107,183 | $57,996 | $80,279 | $55,934 | $49,641 |
| Total Liabilities | $172,247 | $129,556 | $144,051 | $116,797 | $103,619 |
| Shareholders' Equity | |||||
| Common Shares | 1,643 | 1,643 | 1,540 | 1,532 | 1,530 |
| Retained earnings | -27,109 | -6,111 | -73,726 | -362,323 | -42,967 |
| Other shareholders' equity | -425,829 | -428,832 | -337,331 | 546 | -299,039 |
| TOTAL | $-95,584 | $-78,274 | $-71,098 | $-23,452 | $-1,995 |
| Total Liabilities And Equity | $76,663 | $51,282 | $72,953 | $93,345 | $101,624 |